Substance Abuse Treatment Market Report

Japan Substance Abuse Treatment Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 14, 2019
  • PAGES：189
  • REPORT CODE：GMM226988
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Substance Abuse Treatment market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Substance Abuse Treatment market. Detailed analysis of key players, along with key growth strategies adopted by Substance Abuse Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • LFB Group

    • Sterinova

    • Teva Pharmaceutical

    • BioCorRx

    • Amphastar Pharmaceuticals

    • Mylan Laboratories

    • Cipla

    • Sanquin

    • INSYS Therapeutics

    • Allergan

    • AAC Holdings (American Addiction Centers)

    • GSK

    • Accord Healthcare

    • Opiant Technologies

    • Pfizer

    • Sun Pharma

    • Glenmark

    • Apotex

    • Hazelden Betty Ford Foundation

    • Alkermes

    • Lupin

    • Sanofi Aventis


    By Type:

    • Alcohol Addiction Treatment(Disulfiram, Acamprosate, andNaltrexone)

    • Tobacco/Nicotine Addiction

    • Treatment (Nicotine ReplacementTreatment and Non-nicotineMedication)

    • Other Drugs Addiction Treatment(Methadone, Buprenorphine, and Naltrexone)


    By End-User:

    • Outpatient Treatment Centers

    • Residential Treatment Centers

    • Inpatient Treatment Centers

    • Other


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Substance Abuse Treatment Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Substance Abuse Treatment Market Size and Growth Rate of Alcohol Addiction Treatment(Disulfiram, Acamprosate, andNaltrexone) from 2014 to 2026

      • 1.3.2 Japan Substance Abuse Treatment Market Size and Growth Rate of Tobacco/Nicotine Addiction from 2014 to 2026

      • 1.3.3 Japan Substance Abuse Treatment Market Size and Growth Rate of Treatment (Nicotine ReplacementTreatment and Non-nicotineMedication) from 2014 to 2026

      • 1.3.4 Japan Substance Abuse Treatment Market Size and Growth Rate of Other Drugs Addiction Treatment(Methadone, Buprenorphine, and Naltrexone) from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Substance Abuse Treatment Market Size and Growth Rate of Outpatient Treatment Centers from 2014 to 2026

      • 1.4.2 Japan Substance Abuse Treatment Market Size and Growth Rate of Residential Treatment Centers from 2014 to 2026

      • 1.4.3 Japan Substance Abuse Treatment Market Size and Growth Rate of Inpatient Treatment Centers from 2014 to 2026

      • 1.4.4 Japan Substance Abuse Treatment Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Substance Abuse Treatment Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Substance Abuse Treatment Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Substance Abuse Treatment Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Substance Abuse Treatment Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Substance Abuse Treatment Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Substance Abuse Treatment Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Substance Abuse Treatment Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Substance Abuse Treatment Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Substance Abuse Treatment Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Substance Abuse Treatment by Major Types

      • 3.4.1 Market Size and Growth Rate of Alcohol Addiction Treatment(Disulfiram, Acamprosate, andNaltrexone)

      • 3.4.2 Market Size and Growth Rate of Tobacco/Nicotine Addiction

      • 3.4.3 Market Size and Growth Rate of Treatment (Nicotine ReplacementTreatment and Non-nicotineMedication)

      • 3.4.4 Market Size and Growth Rate of Other Drugs Addiction Treatment(Methadone, Buprenorphine, and Naltrexone)

    4 Segmentation of Substance Abuse Treatment Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Substance Abuse Treatment by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Substance Abuse Treatment in Outpatient Treatment Centers

      • 4.4.2 Market Size and Growth Rate of Substance Abuse Treatment in Residential Treatment Centers

      • 4.4.3 Market Size and Growth Rate of Substance Abuse Treatment in Inpatient Treatment Centers

      • 4.4.4 Market Size and Growth Rate of Substance Abuse Treatment in Other


    5 Market Analysis by Regions

    • 5.1 Japan Substance Abuse Treatment Production Analysis by Regions

    • 5.2 Japan Substance Abuse Treatment Consumption Analysis by Regions


    6 Hokkaido Substance Abuse Treatment Landscape Analysis

    • 6.1 Hokkaido Substance Abuse Treatment Landscape Analysis by Major Types

    • 6.2 Hokkaido Substance Abuse Treatment Landscape Analysis by Major End-Users


    7 Tohoku Substance Abuse Treatment Landscape Analysis

    • 7.1 Tohoku Substance Abuse Treatment Landscape Analysis by Major Types

    • 7.2 Tohoku Substance Abuse Treatment Landscape Analysis by Major End-Users


    8 Kanto Substance Abuse Treatment Landscape Analysis

    • 8.1 Kanto Substance Abuse Treatment Landscape Analysis by Major Types

    • 8.2 Kanto Substance Abuse Treatment Landscape Analysis by Major End-Users


    9 Chubu Substance Abuse Treatment Landscape Analysis

    • 9.1 Chubu Substance Abuse Treatment Landscape Analysis by Major Types

    • 9.2 Chubu Substance Abuse Treatment Landscape Analysis by Major End-Users


    10 Kinki Substance Abuse Treatment Landscape Analysis

    • 10.1 Kinki Substance Abuse Treatment Landscape Analysis by Major Types

    • 10.2 Kinki Substance Abuse Treatment Landscape Analysis by Major End-Users


    11 Chugoku Substance Abuse Treatment Landscape Analysis

    • 11.1 Chugoku Substance Abuse Treatment Landscape Analysis by Major Types

    • 11.2 Chugoku Substance Abuse Treatment Landscape Analysis by Major End-Users


    12 Shikoku Substance Abuse Treatment Landscape Analysis

    • 12.1 Shikoku Substance Abuse Treatment Landscape Analysis by Major Types

    • 12.2 Shikoku Substance Abuse Treatment Landscape Analysis by Major End-Users


    13 Kyushu Substance Abuse Treatment Landscape Analysis

    • 13.1 Kyushu Substance Abuse Treatment Landscape Analysis by Major Types

    • 13.2 Kyushu Substance Abuse Treatment Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 LFB Group

      • 14.1.1 LFB Group Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Sterinova

      • 14.2.1 Sterinova Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Teva Pharmaceutical

      • 14.3.1 Teva Pharmaceutical Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 BioCorRx

      • 14.4.1 BioCorRx Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Amphastar Pharmaceuticals

      • 14.5.1 Amphastar Pharmaceuticals Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Mylan Laboratories

      • 14.6.1 Mylan Laboratories Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Cipla

      • 14.7.1 Cipla Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Sanquin

      • 14.8.1 Sanquin Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 INSYS Therapeutics

      • 14.9.1 INSYS Therapeutics Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Allergan

      • 14.10.1 Allergan Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 AAC Holdings (American Addiction Centers)

      • 14.11.1 AAC Holdings (American Addiction Centers) Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 GSK

      • 14.12.1 GSK Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

    • 14.13 Accord Healthcare

      • 14.13.1 Accord Healthcare Company Profile and Recent Development

      • 14.13.2 Market Performance

      • 14.13.3 Product and Service Introduction

    • 14.14 Opiant Technologies

      • 14.14.1 Opiant Technologies Company Profile and Recent Development

      • 14.14.2 Market Performance

      • 14.14.3 Product and Service Introduction

    • 14.15 Pfizer

      • 14.15.1 Pfizer Company Profile and Recent Development

      • 14.15.2 Market Performance

      • 14.15.3 Product and Service Introduction

    • 14.16 Sun Pharma

      • 14.16.1 Sun Pharma Company Profile and Recent Development

      • 14.16.2 Market Performance

      • 14.16.3 Product and Service Introduction

    • 14.17 Glenmark

      • 14.17.1 Glenmark Company Profile and Recent Development

      • 14.17.2 Market Performance

      • 14.17.3 Product and Service Introduction

    • 14.18 Apotex

      • 14.18.1 Apotex Company Profile and Recent Development

      • 14.18.2 Market Performance

      • 14.18.3 Product and Service Introduction

    • 14.19 Hazelden Betty Ford Foundation

      • 14.19.1 Hazelden Betty Ford Foundation Company Profile and Recent Development

      • 14.19.2 Market Performance

      • 14.19.3 Product and Service Introduction

    • 14.20 Alkermes

      • 14.20.1 Alkermes Company Profile and Recent Development

      • 14.20.2 Market Performance

      • 14.20.3 Product and Service Introduction

    • 14.21 Lupin

      • 14.21.1 Lupin Company Profile and Recent Development

      • 14.21.2 Market Performance

      • 14.21.3 Product and Service Introduction

    • 14.22 Sanofi Aventis

      • 14.22.1 Sanofi Aventis Company Profile and Recent Development

      • 14.22.2 Market Performance

      • 14.22.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 80 Figures and 181 Tables)

     

    • Figure Japan Substance Abuse Treatment Market Size and Growth Rate of Alcohol Addiction Treatment(Disulfiram, Acamprosate, andNaltrexone) from 2014 to 2026

    • Figure Japan Substance Abuse Treatment Market Size and Growth Rate of Tobacco/Nicotine Addiction from 2014 to 2026

    • Figure Japan Substance Abuse Treatment Market Size and Growth Rate of Treatment (Nicotine ReplacementTreatment and Non-nicotineMedication) from 2014 to 2026

    • Figure Japan Substance Abuse Treatment Market Size and Growth Rate of Other Drugs Addiction Treatment(Methadone, Buprenorphine, and Naltrexone) from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Substance Abuse Treatment Market Size and Growth Rate of Outpatient Treatment Centers from 2014 to 2026

    • Figure Japan Substance Abuse Treatment Market Size and Growth Rate of Residential Treatment Centers from 2014 to 2026

    • Figure Japan Substance Abuse Treatment Market Size and Growth Rate of Inpatient Treatment Centers from 2014 to 2026

    • Figure Japan Substance Abuse Treatment Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Substance Abuse Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Substance Abuse Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Substance Abuse Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Substance Abuse Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Substance Abuse Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Substance Abuse Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Substance Abuse Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Substance Abuse Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Substance Abuse Treatment Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Substance Abuse Treatment

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Substance Abuse Treatment by Different Types from 2014 to 2026

    • Table Consumption Share of Substance Abuse Treatment by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Alcohol Addiction Treatment(Disulfiram, Acamprosate, andNaltrexone)

    • Figure Market Size and Growth Rate of Tobacco/Nicotine Addiction

    • Figure Market Size and Growth Rate of Treatment (Nicotine ReplacementTreatment and Non-nicotineMedication)

    • Figure Market Size and Growth Rate of Other Drugs Addiction Treatment(Methadone, Buprenorphine, and Naltrexone)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Substance Abuse Treatment by Different End-Users from 2014 to 2026

    • Table Consumption Share of Substance Abuse Treatment by Different End-Users from 2014 to 2026

    • Figure Japan Substance Abuse Treatment Market Size and Growth Rate of Outpatient Treatment Centers from 2014 to 2026

    • Figure Japan Substance Abuse Treatment Market Size and Growth Rate of Residential Treatment Centers from 2014 to 2026

    • Figure Japan Substance Abuse Treatment Market Size and Growth Rate of Inpatient Treatment Centers from 2014 to 2026

    • Figure Japan Substance Abuse Treatment Market Size and Growth Rate of Other from 2014 to 2026

    • Table Japan Substance Abuse Treatment Production by Regions

    • Table Japan Substance Abuse Treatment Production Share by Regions

    • Figure Japan Substance Abuse Treatment Production Share by Regions in 2014

    • Figure Japan Substance Abuse Treatment Production Share by Regions in 2018

    • Figure Japan Substance Abuse Treatment Production Share by Regions in 2026

    • Table Japan Substance Abuse Treatment Consumption by Regions

    • Table Japan Substance Abuse Treatment Consumption Share by Regions

    • Figure Japan Substance Abuse Treatment Consumption Share by Regions in 2014

    • Figure Japan Substance Abuse Treatment Consumption Share by Regions in 2018

    • Figure Japan Substance Abuse Treatment Consumption Share by Regions in 2026

    • Table Hokkaido Substance Abuse Treatment Consumption by Types from 2014 to 2026

    • Table Hokkaido Substance Abuse Treatment Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Substance Abuse Treatment Consumption Share by Types in 2014

    • Figure Hokkaido Substance Abuse Treatment Consumption Share by Types in 2018

    • Figure Hokkaido Substance Abuse Treatment Consumption Share by Types in 2026

    • Table Hokkaido Substance Abuse Treatment Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Substance Abuse Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Substance Abuse Treatment Consumption Share by End-Users in 2014

    • Figure Hokkaido Substance Abuse Treatment Consumption Share by End-Users in 2018

    • Figure Hokkaido Substance Abuse Treatment Consumption Share by End-Users in 2026

    • Table Tohoku Substance Abuse Treatment Consumption by Types from 2014 to 2026

    • Table Tohoku Substance Abuse Treatment Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Substance Abuse Treatment Consumption Share by Types in 2014

    • Figure Tohoku Substance Abuse Treatment Consumption Share by Types in 2018

    • Figure Tohoku Substance Abuse Treatment Consumption Share by Types in 2026

    • Table Tohoku Substance Abuse Treatment Consumption by End-Users from 2014 to 2026

    • Table Tohoku Substance Abuse Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Substance Abuse Treatment Consumption Share by End-Users in 2014

    • Figure Tohoku Substance Abuse Treatment Consumption Share by End-Users in 2018

    • Figure Tohoku Substance Abuse Treatment Consumption Share by End-Users in 2026

    • Table Kanto Substance Abuse Treatment Consumption by Types from 2014 to 2026

    • Table Kanto Substance Abuse Treatment Consumption Share by Types from 2014 to 2026

    • Figure Kanto Substance Abuse Treatment Consumption Share by Types in 2014

    • Figure Kanto Substance Abuse Treatment Consumption Share by Types in 2018

    • Figure Kanto Substance Abuse Treatment Consumption Share by Types in 2026

    • Table Kanto Substance Abuse Treatment Consumption by End-Users from 2014 to 2026

    • Table Kanto Substance Abuse Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Substance Abuse Treatment Consumption Share by End-Users in 2014

    • Figure Kanto Substance Abuse Treatment Consumption Share by End-Users in 2018

    • Figure Kanto Substance Abuse Treatment Consumption Share by End-Users in 2026

    • Table Chubu Substance Abuse Treatment Consumption by Types from 2014 to 2026

    • Table Chubu Substance Abuse Treatment Consumption Share by Types from 2014 to 2026

    • Figure Chubu Substance Abuse Treatment Consumption Share by Types in 2014

    • Figure Chubu Substance Abuse Treatment Consumption Share by Types in 2018

    • Figure Chubu Substance Abuse Treatment Consumption Share by Types in 2026

    • Table Chubu Substance Abuse Treatment Consumption by End-Users from 2014 to 2026

    • Table Chubu Substance Abuse Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Substance Abuse Treatment Consumption Share by End-Users in 2014

    • Figure Chubu Substance Abuse Treatment Consumption Share by End-Users in 2018

    • Figure Chubu Substance Abuse Treatment Consumption Share by End-Users in 2026

    • Table Kinki Substance Abuse Treatment Consumption by Types from 2014 to 2026

    • Table Kinki Substance Abuse Treatment Consumption Share by Types from 2014 to 2026

    • Figure Kinki Substance Abuse Treatment Consumption Share by Types in 2014

    • Figure Kinki Substance Abuse Treatment Consumption Share by Types in 2018

    • Figure Kinki Substance Abuse Treatment Consumption Share by Types in 2026

    • Table Kinki Substance Abuse Treatment Consumption by End-Users from 2014 to 2026

    • Table Kinki Substance Abuse Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Substance Abuse Treatment Consumption Share by End-Users in 2014

    • Figure Kinki Substance Abuse Treatment Consumption Share by End-Users in 2018

    • Figure Kinki Substance Abuse Treatment Consumption Share by End-Users in 2026

    • Table Chugoku Substance Abuse Treatment Consumption by Types from 2014 to 2026

    • Table Chugoku Substance Abuse Treatment Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Substance Abuse Treatment Consumption Share by Types in 2014

    • Figure Chugoku Substance Abuse Treatment Consumption Share by Types in 2018

    • Figure Chugoku Substance Abuse Treatment Consumption Share by Types in 2026

    • Table Chugoku Substance Abuse Treatment Consumption by End-Users from 2014 to 2026

    • Table Chugoku Substance Abuse Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Substance Abuse Treatment Consumption Share by End-Users in 2014

    • Figure Chugoku Substance Abuse Treatment Consumption Share by End-Users in 2018

    • Figure Chugoku Substance Abuse Treatment Consumption Share by End-Users in 2026

    • Table Shikoku Substance Abuse Treatment Consumption by Types from 2014 to 2026

    • Table Shikoku Substance Abuse Treatment Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Substance Abuse Treatment Consumption Share by Types in 2014

    • Figure Shikoku Substance Abuse Treatment Consumption Share by Types in 2018

    • Figure Shikoku Substance Abuse Treatment Consumption Share by Types in 2026

    • Table Shikoku Substance Abuse Treatment Consumption by End-Users from 2014 to 2026

    • Table Shikoku Substance Abuse Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Substance Abuse Treatment Consumption Share by End-Users in 2014

    • Figure Shikoku Substance Abuse Treatment Consumption Share by End-Users in 2018

    • Figure Shikoku Substance Abuse Treatment Consumption Share by End-Users in 2026

    • Table Kyushu Substance Abuse Treatment Consumption by Types from 2014 to 2026

    • Table Kyushu Substance Abuse Treatment Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Substance Abuse Treatment Consumption Share by Types in 2014

    • Figure Kyushu Substance Abuse Treatment Consumption Share by Types in 2018

    • Figure Kyushu Substance Abuse Treatment Consumption Share by Types in 2026

    • Table Kyushu Substance Abuse Treatment Consumption by End-Users from 2014 to 2026

    • Table Kyushu Substance Abuse Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Substance Abuse Treatment Consumption Share by End-Users in 2014

    • Figure Kyushu Substance Abuse Treatment Consumption Share by End-Users in 2018

    • Figure Kyushu Substance Abuse Treatment Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of LFB Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LFB Group

    • Figure Sales and Growth Rate Analysis of LFB Group

    • Figure Revenue and Market Share Analysis of LFB Group

    • Table Product and Service Introduction of LFB Group

    • Table Company Profile and Development Status of Sterinova

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sterinova

    • Figure Sales and Growth Rate Analysis of Sterinova

    • Figure Revenue and Market Share Analysis of Sterinova

    • Table Product and Service Introduction of Sterinova

    • Table Company Profile and Development Status of Teva Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical

    • Table Product and Service Introduction of Teva Pharmaceutical

    • Table Company Profile and Development Status of BioCorRx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioCorRx

    • Figure Sales and Growth Rate Analysis of BioCorRx

    • Figure Revenue and Market Share Analysis of BioCorRx

    • Table Product and Service Introduction of BioCorRx

    • Table Company Profile and Development Status of Amphastar Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amphastar Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Amphastar Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Amphastar Pharmaceuticals

    • Table Product and Service Introduction of Amphastar Pharmaceuticals

    • Table Company Profile and Development Status of Mylan Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan Laboratories

    • Figure Sales and Growth Rate Analysis of Mylan Laboratories

    • Figure Revenue and Market Share Analysis of Mylan Laboratories

    • Table Product and Service Introduction of Mylan Laboratories

    • Table Company Profile and Development Status of Cipla

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla

    • Figure Sales and Growth Rate Analysis of Cipla

    • Figure Revenue and Market Share Analysis of Cipla

    • Table Product and Service Introduction of Cipla

    • Table Company Profile and Development Status of Sanquin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanquin

    • Figure Sales and Growth Rate Analysis of Sanquin

    • Figure Revenue and Market Share Analysis of Sanquin

    • Table Product and Service Introduction of Sanquin

    • Table Company Profile and Development Status of INSYS Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of INSYS Therapeutics

    • Figure Sales and Growth Rate Analysis of INSYS Therapeutics

    • Figure Revenue and Market Share Analysis of INSYS Therapeutics

    • Table Product and Service Introduction of INSYS Therapeutics

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of AAC Holdings (American Addiction Centers)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AAC Holdings (American Addiction Centers)

    • Figure Sales and Growth Rate Analysis of AAC Holdings (American Addiction Centers)

    • Figure Revenue and Market Share Analysis of AAC Holdings (American Addiction Centers)

    • Table Product and Service Introduction of AAC Holdings (American Addiction Centers)

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Accord Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Accord Healthcare

    • Figure Sales and Growth Rate Analysis of Accord Healthcare

    • Figure Revenue and Market Share Analysis of Accord Healthcare

    • Table Product and Service Introduction of Accord Healthcare

    • Table Company Profile and Development Status of Opiant Technologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Opiant Technologies

    • Figure Sales and Growth Rate Analysis of Opiant Technologies

    • Figure Revenue and Market Share Analysis of Opiant Technologies

    • Table Product and Service Introduction of Opiant Technologies

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Sun Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharma

    • Figure Sales and Growth Rate Analysis of Sun Pharma

    • Figure Revenue and Market Share Analysis of Sun Pharma

    • Table Product and Service Introduction of Sun Pharma

    • Table Company Profile and Development Status of Glenmark

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glenmark

    • Figure Sales and Growth Rate Analysis of Glenmark

    • Figure Revenue and Market Share Analysis of Glenmark

    • Table Product and Service Introduction of Glenmark

    • Table Company Profile and Development Status of Apotex

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Apotex

    • Figure Sales and Growth Rate Analysis of Apotex

    • Figure Revenue and Market Share Analysis of Apotex

    • Table Product and Service Introduction of Apotex

    • Table Company Profile and Development Status of Hazelden Betty Ford Foundation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hazelden Betty Ford Foundation

    • Figure Sales and Growth Rate Analysis of Hazelden Betty Ford Foundation

    • Figure Revenue and Market Share Analysis of Hazelden Betty Ford Foundation

    • Table Product and Service Introduction of Hazelden Betty Ford Foundation

    • Table Company Profile and Development Status of Alkermes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alkermes

    • Figure Sales and Growth Rate Analysis of Alkermes

    • Figure Revenue and Market Share Analysis of Alkermes

    • Table Product and Service Introduction of Alkermes

    • Table Company Profile and Development Status of Lupin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lupin

    • Figure Sales and Growth Rate Analysis of Lupin

    • Figure Revenue and Market Share Analysis of Lupin

    • Table Product and Service Introduction of Lupin

    • Table Company Profile and Development Status of Sanofi Aventis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Aventis

    • Figure Sales and Growth Rate Analysis of Sanofi Aventis

    • Figure Revenue and Market Share Analysis of Sanofi Aventis

    • Table Product and Service Introduction of Sanofi Aventis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US